Loading
9 results ( 0 unique IP ) ,632 ms ,Keyword Search.
Nearly year results, click to view all results.
智能排除蜜罐/仿冒数据 0 条， 点击 查看。
API
Lastupdate time
All
- All
- Protocol
- Website
Fields
共 9 条
- 10条/页
无数据
- 1
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-12-04
Header
Banner
Products
CName
HTTP/1.1 302 Moved Temporarily
Cache-Control: no-cache
Pragma: no-cache
Location: https://199.255.29.164/owa/
Server: Microsoft-IIS/10.0
X-FEServer: NP-BV-MSX-02
X-RequestId: a0b49895-dadf-471e-886a-3589482e0cf2
Date: Wed, 04 Dec 2024 08:38:45 GMT
Connection: close
Content-Length: 0
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:mail.neopharmlabs.com
Version: v3
Serial Number: 104317252153884149208359703734813736191
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2023-12-05 00:00 UTC
Not After : 2025-01-04 23:59 UTC
Subject:
CommonName: mail.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (2048 bits) :
C5:EE:D0:BA:A3:9A:4A:A0:63:3D:0E:6E:73:D6:FC:8B:
A2:65:40:35:9C:9B:D4:E4:E3:AA:DB:E9:72:BC:C8:14:
27:B2:A3:93:5F:FA:A4:0A:6D:79:D8:BF:75:4F:5A:E7:
B2:B7:BA:52:3A:51:58:E5:9B:90:93:84:A9:EA:BD:77:
E4:85:37:87:3D:BB:6E:4E:BD:31:37:E2:02:C5:B2:9A:
A5:E4:CC:CA:BE:56:5B:D2:7A:E0:C4:A9:51:79:63:A0:
67:B0:44:61:74:DC:6B:8E:0D:18:12:8D:6C:93:34:D7:
07:37:86:8C:C3:86:5D:C9:1B:5E:46:86:8C:8A:3B:C0:
70:67:BA:51:66:9B:8E:B1:3A:59:8D:1B:75:0D:B7:6D:
A4:2A:18:F1:D6:42:11:E6:8F:F9:DE:E9:B8:AA:11:9F:
E8:D1:E0:8F:78:56:72:A5:FC:A7:92:E0:AE:FB:F7:CB:
F0:38:4E:79:AA:7B:23:D2:21:B3:81:DF:89:E3:CF:BA:
CD:31:F6:9C:75:71:91:B1:7F:67:45:25:E6:DD:C1:26:
D5:A4:E6:04:49:B0:F8:2C:6D:21:41:26:83:25:04:AB:
52:72:90:E9:3E:73:CA:FF:50:90:FE:D2:82:67:47:F9:
F2:33:9C:91:7F:06:84:D1:34:4D:91:88:C7:DC:5A:2F
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
36:DC:26:B6:F1:33:50:DE:DF:68:C8:4E:96:84:22:5D:59:64:A3:0C
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
mail.neopharmlabs.com
www.mail.neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
D5:FC:82:E8:A8:D2:EA:E0:6B:47:61:BC:2D:9D:6B:81:
21:B9:59:49:5B:D2:8B:71:7E:56:F5:47:88:5C:C4:74:
38:E4:0C:25:9D:A9:04:9B:B4:9D:15:34:CD:D4:13:74:
FA:59:D5:74:6D:2A:4D:B4:E4:03:39:95:4C:7B:81:07:
28:CD:FE:6B:16:5C:11:28:75:9F:96:45:EC:8F:19:25:
26:65:58:CE:EE:3E:2A:38:0F:A2:31:0D:91:C6:F4:99:
1C:39:D8:1A:00:78:CE:0B:24:14:E8:33:A3:2C:66:65:
5C:EA:0A:B6:29:3D:D6:C3:18:12:A2:78:20:46:C6:A6:
07:A3:94:09:78:73:29:43:FD:8C:7C:C3:DC:57:71:13:
B5:73:AF:2B:13:2C:58:F8:A6:76:A7:3C:A5:66:8D:8B:
11:CE:D3:7C:42:F6:9A:2C:4E:F4:57:BF:8B:44:64:F7:
89:E8:E3:45:94:96:8D:C8:D7:ED:2A:89:E8:BA:3B:EF:
FD:D7:59:19:B4:1F:1C:16:25:9D:84:87:FD:46:CD:91:
AF:F7:42:32:03:16:4D:03:74:28:1B:5E:59:E2:64:F6:
AA:B4:40:2A:D0:6C:CB:FD:89:DB:35:E2:51:34:5C:B0:
CE:F6:54:42:E2:EF:26:D7:0A:7D:5E:ED:4B:E3:11:29
199.255.29.164:500
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-12-03
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-11-29
Header
Banner
Products
CName
HTTP/1.1 404 Not Found
Date: Fri, 29 Nov 2024 03:00:47 GMT
Content-Type: text/html
Content-Length: 134
Connection: keep-alive
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Strict-Transport-Security: max-age=31536000
Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
X-Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
X-Webkit-CSP: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:*.neopharmlabs.com
Version: v3
Serial Number: 150982231862736926028309733667027498732
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2024-07-12 00:00 UTC
Not After : 2025-08-12 23:59 UTC
Subject:
CommonName: *.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (4096 bits) :
ED:EE:27:09:A8:E3:49:71:26:DB:B7:69:67:10:ED:F0:
D1:98:67:44:CA:58:52:1D:2A:63:FC:B8:E9:9F:40:8B:
E1:BF:AF:A5:C7:20:15:04:D1:36:86:3D:46:75:9D:F0:
7C:C5:14:EF:9B:9B:71:CD:0D:5B:4D:34:01:1B:D2:02:
21:19:D6:AC:57:59:29:0A:88:6F:6A:DA:42:98:F9:CB:
08:24:2E:1F:E2:17:D2:AA:EB:C7:57:44:46:A8:34:E6:
E9:D9:74:BC:2B:74:73:3E:3A:A9:7F:2F:AC:AC:43:E4:
74:77:2D:59:59:F2:27:3E:81:81:91:B3:80:8A:04:6F:
52:A1:DB:73:39:A6:B1:BE:08:43:94:3B:02:EC:F3:E0:
DC:81:2F:AA:C5:24:20:FB:20:B6:A1:5E:33:D9:E6:49:
22:E9:5A:4C:74:5D:52:A6:CD:1D:9B:38:EB:BB:DA:94:
44:C3:D8:D2:BE:A7:47:9D:F7:40:BA:6D:69:7F:66:18:
38:30:39:E4:1F:83:B6:AA:D2:46:59:B1:E7:71:FF:1C:
80:7A:59:45:CC:3A:F5:C8:7B:49:68:96:71:79:2E:86:
8D:BB:05:FA:A4:39:35:B6:94:86:2F:04:EE:EE:86:76:
51:9A:A0:05:44:31:D2:2D:5B:49:B0:25:B7:A2:C0:F1:
69:E8:74:96:60:40:2A:E8:39:72:EB:C5:F7:52:58:24:
4E:68:74:D4:9D:41:75:CE:2B:DF:E7:DE:6E:58:22:0E:
08:5F:1B:AC:77:BE:D5:02:15:16:23:1E:48:80:A5:45:
C9:A4:F4:BA:5F:D6:30:86:B7:94:4E:80:E4:7B:D9:DC:
CD:DC:CD:4B:0C:62:34:AC:1F:9E:D8:BB:3A:7B:87:9A:
B7:6B:34:E2:54:02:BF:7F:A0:A7:A4:E6:D9:AB:4D:46:
C7:77:3D:EA:1B:25:5F:89:FB:B5:1C:39:F5:5A:00:46:
81:11:D5:90:0F:47:AF:80:B7:CF:07:29:E4:92:57:FA:
56:F4:ED:AE:39:6F:8C:65:90:43:6D:C0:DF:A6:8A:49:
2C:D8:EC:F0:B0:AA:09:BD:33:07:61:5E:BE:51:BB:1B:
BF:1B:76:C7:2F:76:F4:D3:18:CB:C6:CA:D5:BC:90:D2:
A7:40:15:A3:BB:1E:D6:DF:95:A0:24:FB:1E:A3:B6:4F:
D6:F2:56:96:24:CE:7C:9D:7D:64:36:60:72:CC:38:83:
F3:7E:C9:86:B1:8A:3C:37:97:37:C0:89:59:6A:07:C5:
17:9F:36:8E:B2:39:61:65:C5:EE:57:78:CE:E8:6C:E0:
37:65:9B:0B:61:F3:AF:25:04:89:AF:7B:7D:48:FA:65
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
DC:E2:80:BA:5A:E4:E5:3E:67:67:9A:71:E9:C0:A6:FF:08:4F:C4:79
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
*.neopharmlabs.com
neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
B0:53:6F:3C:64:91:81:F6:00:5A:D9:F2:8C:92:E3:A9:
FA:B7:99:BA:E2:BC:4A:BE:0B:9E:64:E2:99:65:37:3C:
96:76:DB:36:EE:53:A5:B2:B2:76:76:49:C9:93:35:C2:
31:78:FD:6D:C1:C5:31:86:C3:45:4A:14:EB:10:8F:5B:
84:81:A9:4B:57:55:C1:E6:4D:05:11:18:C6:28:EC:F8:
CF:B3:DA:9C:15:33:82:DE:A5:26:1A:8D:33:C9:89:54:
65:2F:73:9E:83:DB:2F:0D:E3:7D:A8:DD:D0:FA:DA:30:
DF:2E:FF:58:83:82:C9:96:12:2C:00:99:E8:C9:4A:B8:
2F:8E:CA:4B:2F:EC:C0:28:F8:C2:A4:AA:8F:3D:26:D8:
14:5F:FA:BF:05:CF:A5:29:22:0D:AB:6F:2D:77:BF:A4:
74:9B:69:27:D7:34:13:06:43:8D:88:91:F3:20:12:94:
79:01:CD:E9:E7:0D:AB:89:9C:D6:07:6B:F6:95:30:AB:
3B:2F:57:67:A2:27:07:66:0F:33:F8:72:39:00:B5:0A:
E9:82:35:2F:66:6E:D1:A0:0C:96:E3:66:47:D6:B3:A2:
34:DD:A5:1A:B9:BB:4E:10:70:BE:9E:A9:13:40:AE:E8:
F0:AD:B0:3B:9E:6A:BA:65:76:3D:A9:4F:F6:6B:C8:99
Outlook
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
neopharmlabs.com neopharmlabs.com
2024-11-23
Header
Banner
Products
CName
HTTP/1.1 200 OK
Connection: close
Content-Length: 28278
Cache-Control: no-cache, no-store
Content-Type: text/html; charset=utf-8
Date: Fri, 22 Nov 2024 19:03:52 GMT
Expires: -1
Pragma: no-cache
Request-Id: fe05ca43-d7df-4b19-bb8e-30d058b8dfea
Server: Microsoft-IIS/10.0
X-Aspnet-Version: 4.0.30319
X-Frame-Options: SAMEORIGIN
X-Powered-By: ASP.NET
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:mail.neopharmlabs.com
Version: v3
Serial Number: 104317252153884149208359703734813736191
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2023-12-05 00:00 UTC
Not After : 2025-01-04 23:59 UTC
Subject:
CommonName: mail.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (2048 bits) :
C5:EE:D0:BA:A3:9A:4A:A0:63:3D:0E:6E:73:D6:FC:8B:
A2:65:40:35:9C:9B:D4:E4:E3:AA:DB:E9:72:BC:C8:14:
27:B2:A3:93:5F:FA:A4:0A:6D:79:D8:BF:75:4F:5A:E7:
B2:B7:BA:52:3A:51:58:E5:9B:90:93:84:A9:EA:BD:77:
E4:85:37:87:3D:BB:6E:4E:BD:31:37:E2:02:C5:B2:9A:
A5:E4:CC:CA:BE:56:5B:D2:7A:E0:C4:A9:51:79:63:A0:
67:B0:44:61:74:DC:6B:8E:0D:18:12:8D:6C:93:34:D7:
07:37:86:8C:C3:86:5D:C9:1B:5E:46:86:8C:8A:3B:C0:
70:67:BA:51:66:9B:8E:B1:3A:59:8D:1B:75:0D:B7:6D:
A4:2A:18:F1:D6:42:11:E6:8F:F9:DE:E9:B8:AA:11:9F:
E8:D1:E0:8F:78:56:72:A5:FC:A7:92:E0:AE:FB:F7:CB:
F0:38:4E:79:AA:7B:23:D2:21:B3:81:DF:89:E3:CF:BA:
CD:31:F6:9C:75:71:91:B1:7F:67:45:25:E6:DD:C1:26:
D5:A4:E6:04:49:B0:F8:2C:6D:21:41:26:83:25:04:AB:
52:72:90:E9:3E:73:CA:FF:50:90:FE:D2:82:67:47:F9:
F2:33:9C:91:7F:06:84:D1:34:4D:91:88:C7:DC:5A:2F
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
36:DC:26:B6:F1:33:50:DE:DF:68:C8:4E:96:84:22:5D:59:64:A3:0C
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
mail.neopharmlabs.com
www.mail.neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
D5:FC:82:E8:A8:D2:EA:E0:6B:47:61:BC:2D:9D:6B:81:
21:B9:59:49:5B:D2:8B:71:7E:56:F5:47:88:5C:C4:74:
38:E4:0C:25:9D:A9:04:9B:B4:9D:15:34:CD:D4:13:74:
FA:59:D5:74:6D:2A:4D:B4:E4:03:39:95:4C:7B:81:07:
28:CD:FE:6B:16:5C:11:28:75:9F:96:45:EC:8F:19:25:
26:65:58:CE:EE:3E:2A:38:0F:A2:31:0D:91:C6:F4:99:
1C:39:D8:1A:00:78:CE:0B:24:14:E8:33:A3:2C:66:65:
5C:EA:0A:B6:29:3D:D6:C3:18:12:A2:78:20:46:C6:A6:
07:A3:94:09:78:73:29:43:FD:8C:7C:C3:DC:57:71:13:
B5:73:AF:2B:13:2C:58:F8:A6:76:A7:3C:A5:66:8D:8B:
11:CE:D3:7C:42:F6:9A:2C:4E:F4:57:BF:8B:44:64:F7:
89:E8:E3:45:94:96:8D:C8:D7:ED:2A:89:E8:BA:3B:EF:
FD:D7:59:19:B4:1F:1C:16:25:9D:84:87:FD:46:CD:91:
AF:F7:42:32:03:16:4D:03:74:28:1B:5E:59:E2:64:F6:
AA:B4:40:2A:D0:6C:CB:FD:89:DB:35:E2:51:34:5C:B0:
CE:F6:54:42:E2:EF:26:D7:0A:7D:5E:ED:4B:E3:11:29
Outlook
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-11-23
Header
Banner
Products
CName
HTTP/1.1 200 OK
Connection: close
Content-Length: 28264
Cache-Control: no-cache, no-store
Content-Type: text/html; charset=utf-8
Date: Fri, 22 Nov 2024 18:52:56 GMT
Expires: -1
Pragma: no-cache
Request-Id: f06f94cf-6cda-4d7e-8e58-5abe33e7ebaa
Server: Microsoft-IIS/10.0
X-Aspnet-Version: 4.0.30319
X-Frame-Options: SAMEORIGIN
X-Powered-By: ASP.NET
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:mail.neopharmlabs.com
Version: v3
Serial Number: 104317252153884149208359703734813736191
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2023-12-05 00:00 UTC
Not After : 2025-01-04 23:59 UTC
Subject:
CommonName: mail.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (2048 bits) :
C5:EE:D0:BA:A3:9A:4A:A0:63:3D:0E:6E:73:D6:FC:8B:
A2:65:40:35:9C:9B:D4:E4:E3:AA:DB:E9:72:BC:C8:14:
27:B2:A3:93:5F:FA:A4:0A:6D:79:D8:BF:75:4F:5A:E7:
B2:B7:BA:52:3A:51:58:E5:9B:90:93:84:A9:EA:BD:77:
E4:85:37:87:3D:BB:6E:4E:BD:31:37:E2:02:C5:B2:9A:
A5:E4:CC:CA:BE:56:5B:D2:7A:E0:C4:A9:51:79:63:A0:
67:B0:44:61:74:DC:6B:8E:0D:18:12:8D:6C:93:34:D7:
07:37:86:8C:C3:86:5D:C9:1B:5E:46:86:8C:8A:3B:C0:
70:67:BA:51:66:9B:8E:B1:3A:59:8D:1B:75:0D:B7:6D:
A4:2A:18:F1:D6:42:11:E6:8F:F9:DE:E9:B8:AA:11:9F:
E8:D1:E0:8F:78:56:72:A5:FC:A7:92:E0:AE:FB:F7:CB:
F0:38:4E:79:AA:7B:23:D2:21:B3:81:DF:89:E3:CF:BA:
CD:31:F6:9C:75:71:91:B1:7F:67:45:25:E6:DD:C1:26:
D5:A4:E6:04:49:B0:F8:2C:6D:21:41:26:83:25:04:AB:
52:72:90:E9:3E:73:CA:FF:50:90:FE:D2:82:67:47:F9:
F2:33:9C:91:7F:06:84:D1:34:4D:91:88:C7:DC:5A:2F
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
36:DC:26:B6:F1:33:50:DE:DF:68:C8:4E:96:84:22:5D:59:64:A3:0C
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
mail.neopharmlabs.com
www.mail.neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
D5:FC:82:E8:A8:D2:EA:E0:6B:47:61:BC:2D:9D:6B:81:
21:B9:59:49:5B:D2:8B:71:7E:56:F5:47:88:5C:C4:74:
38:E4:0C:25:9D:A9:04:9B:B4:9D:15:34:CD:D4:13:74:
FA:59:D5:74:6D:2A:4D:B4:E4:03:39:95:4C:7B:81:07:
28:CD:FE:6B:16:5C:11:28:75:9F:96:45:EC:8F:19:25:
26:65:58:CE:EE:3E:2A:38:0F:A2:31:0D:91:C6:F4:99:
1C:39:D8:1A:00:78:CE:0B:24:14:E8:33:A3:2C:66:65:
5C:EA:0A:B6:29:3D:D6:C3:18:12:A2:78:20:46:C6:A6:
07:A3:94:09:78:73:29:43:FD:8C:7C:C3:DC:57:71:13:
B5:73:AF:2B:13:2C:58:F8:A6:76:A7:3C:A5:66:8D:8B:
11:CE:D3:7C:42:F6:9A:2C:4E:F4:57:BF:8B:44:64:F7:
89:E8:E3:45:94:96:8D:C8:D7:ED:2A:89:E8:BA:3B:EF:
FD:D7:59:19:B4:1F:1C:16:25:9D:84:87:FD:46:CD:91:
AF:F7:42:32:03:16:4D:03:74:28:1B:5E:59:E2:64:F6:
AA:B4:40:2A:D0:6C:CB:FD:89:DB:35:E2:51:34:5C:B0:
CE:F6:54:42:E2:EF:26:D7:0A:7D:5E:ED:4B:E3:11:29
404 Not Found
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-11-21
Header
Banner
Products
CName
HTTP/1.1 404 Not Found
Connection: close
Content-Length: 536
Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
Content-Type: text/html
Date: Wed, 20 Nov 2024 21:06:46 GMT
Strict-Transport-Security: max-age=31536000
X-Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
X-Content-Type-Options: nosniff
X-Webkit-Csp: default-src 'self'; script-src 'self' 'unsafe-eval' 'unsafe-inline'; style-src 'self' 'unsafe-inline'; img-src 'self' data:; connect-src 'self'; font-src 'self'; object-src 'self'; media-src 'self'; child-src 'self'
X-Xss-Protection: 1; mode=block
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:*.neopharmlabs.com
Version: v3
Serial Number: 150982231862736926028309733667027498732
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2024-07-12 00:00 UTC
Not After : 2025-08-12 23:59 UTC
Subject:
CommonName: *.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (4096 bits) :
ED:EE:27:09:A8:E3:49:71:26:DB:B7:69:67:10:ED:F0:
D1:98:67:44:CA:58:52:1D:2A:63:FC:B8:E9:9F:40:8B:
E1:BF:AF:A5:C7:20:15:04:D1:36:86:3D:46:75:9D:F0:
7C:C5:14:EF:9B:9B:71:CD:0D:5B:4D:34:01:1B:D2:02:
21:19:D6:AC:57:59:29:0A:88:6F:6A:DA:42:98:F9:CB:
08:24:2E:1F:E2:17:D2:AA:EB:C7:57:44:46:A8:34:E6:
E9:D9:74:BC:2B:74:73:3E:3A:A9:7F:2F:AC:AC:43:E4:
74:77:2D:59:59:F2:27:3E:81:81:91:B3:80:8A:04:6F:
52:A1:DB:73:39:A6:B1:BE:08:43:94:3B:02:EC:F3:E0:
DC:81:2F:AA:C5:24:20:FB:20:B6:A1:5E:33:D9:E6:49:
22:E9:5A:4C:74:5D:52:A6:CD:1D:9B:38:EB:BB:DA:94:
44:C3:D8:D2:BE:A7:47:9D:F7:40:BA:6D:69:7F:66:18:
38:30:39:E4:1F:83:B6:AA:D2:46:59:B1:E7:71:FF:1C:
80:7A:59:45:CC:3A:F5:C8:7B:49:68:96:71:79:2E:86:
8D:BB:05:FA:A4:39:35:B6:94:86:2F:04:EE:EE:86:76:
51:9A:A0:05:44:31:D2:2D:5B:49:B0:25:B7:A2:C0:F1:
69:E8:74:96:60:40:2A:E8:39:72:EB:C5:F7:52:58:24:
4E:68:74:D4:9D:41:75:CE:2B:DF:E7:DE:6E:58:22:0E:
08:5F:1B:AC:77:BE:D5:02:15:16:23:1E:48:80:A5:45:
C9:A4:F4:BA:5F:D6:30:86:B7:94:4E:80:E4:7B:D9:DC:
CD:DC:CD:4B:0C:62:34:AC:1F:9E:D8:BB:3A:7B:87:9A:
B7:6B:34:E2:54:02:BF:7F:A0:A7:A4:E6:D9:AB:4D:46:
C7:77:3D:EA:1B:25:5F:89:FB:B5:1C:39:F5:5A:00:46:
81:11:D5:90:0F:47:AF:80:B7:CF:07:29:E4:92:57:FA:
56:F4:ED:AE:39:6F:8C:65:90:43:6D:C0:DF:A6:8A:49:
2C:D8:EC:F0:B0:AA:09:BD:33:07:61:5E:BE:51:BB:1B:
BF:1B:76:C7:2F:76:F4:D3:18:CB:C6:CA:D5:BC:90:D2:
A7:40:15:A3:BB:1E:D6:DF:95:A0:24:FB:1E:A3:B6:4F:
D6:F2:56:96:24:CE:7C:9D:7D:64:36:60:72:CC:38:83:
F3:7E:C9:86:B1:8A:3C:37:97:37:C0:89:59:6A:07:C5:
17:9F:36:8E:B2:39:61:65:C5:EE:57:78:CE:E8:6C:E0:
37:65:9B:0B:61:F3:AF:25:04:89:AF:7B:7D:48:FA:65
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
DC:E2:80:BA:5A:E4:E5:3E:67:67:9A:71:E9:C0:A6:FF:08:4F:C4:79
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
*.neopharmlabs.com
neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
B0:53:6F:3C:64:91:81:F6:00:5A:D9:F2:8C:92:E3:A9:
FA:B7:99:BA:E2:BC:4A:BE:0B:9E:64:E2:99:65:37:3C:
96:76:DB:36:EE:53:A5:B2:B2:76:76:49:C9:93:35:C2:
31:78:FD:6D:C1:C5:31:86:C3:45:4A:14:EB:10:8F:5B:
84:81:A9:4B:57:55:C1:E6:4D:05:11:18:C6:28:EC:F8:
CF:B3:DA:9C:15:33:82:DE:A5:26:1A:8D:33:C9:89:54:
65:2F:73:9E:83:DB:2F:0D:E3:7D:A8:DD:D0:FA:DA:30:
DF:2E:FF:58:83:82:C9:96:12:2C:00:99:E8:C9:4A:B8:
2F:8E:CA:4B:2F:EC:C0:28:F8:C2:A4:AA:8F:3D:26:D8:
14:5F:FA:BF:05:CF:A5:29:22:0D:AB:6F:2D:77:BF:A4:
74:9B:69:27:D7:34:13:06:43:8D:88:91:F3:20:12:94:
79:01:CD:E9:E7:0D:AB:89:9C:D6:07:6B:F6:95:30:AB:
3B:2F:57:67:A2:27:07:66:0F:33:F8:72:39:00:B5:0A:
E9:82:35:2F:66:6E:D1:A0:0C:96:E3:66:47:D6:B3:A2:
34:DD:A5:1A:B9:BB:4E:10:70:BE:9E:A9:13:40:AE:E8:
F0:AD:B0:3B:9E:6A:BA:65:76:3D:A9:4F:F6:6B:C8:99
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
neopharmlabs.com neopharmlabs.com
2024-06-04
Header
Banner
Products
CName
HTTP/1.1 302 Moved Temporarily
Cache-Control: no-cache
Pragma: no-cache
Location: https://199.255.29.164/owa/
Server: Microsoft-IIS/10.0
X-FEServer: NP-BV-MSX-02
X-RequestId: 3dc2f7e8-782d-4d7f-8503-64d951b319b9
Date: Mon, 03 Jun 2024 17:04:52 GMT
Connection: close
Content-Length: 0
Issuer
Organization:Sectigo Limited
CommonName:Sectigo RSA Domain Validation Secure Server CA
Validity
ValidType:
Subject
Organization:
CommonName:mail.neopharmlabs.com
Version: v3
Serial Number: 104317252153884149208359703734813736191
Signature Algorithm: SHA256-RSA
Issuer:
Country: GB
Province: Greater Manchester
Locality: Salford
Organization: Sectigo Limited
CommonName: Sectigo RSA Domain Validation Secure Server CA
Validity:
Not Before: 2023-12-05 00:00 UTC
Not After : 2025-01-04 23:59 UTC
Subject:
CommonName: mail.neopharmlabs.com
Subject Public Key Info:
Public Key Algorithm: RSA
Public Key:
Exponent: 65537
Public Key Modulus: (2048 bits) :
C5:EE:D0:BA:A3:9A:4A:A0:63:3D:0E:6E:73:D6:FC:8B:
A2:65:40:35:9C:9B:D4:E4:E3:AA:DB:E9:72:BC:C8:14:
27:B2:A3:93:5F:FA:A4:0A:6D:79:D8:BF:75:4F:5A:E7:
B2:B7:BA:52:3A:51:58:E5:9B:90:93:84:A9:EA:BD:77:
E4:85:37:87:3D:BB:6E:4E:BD:31:37:E2:02:C5:B2:9A:
A5:E4:CC:CA:BE:56:5B:D2:7A:E0:C4:A9:51:79:63:A0:
67:B0:44:61:74:DC:6B:8E:0D:18:12:8D:6C:93:34:D7:
07:37:86:8C:C3:86:5D:C9:1B:5E:46:86:8C:8A:3B:C0:
70:67:BA:51:66:9B:8E:B1:3A:59:8D:1B:75:0D:B7:6D:
A4:2A:18:F1:D6:42:11:E6:8F:F9:DE:E9:B8:AA:11:9F:
E8:D1:E0:8F:78:56:72:A5:FC:A7:92:E0:AE:FB:F7:CB:
F0:38:4E:79:AA:7B:23:D2:21:B3:81:DF:89:E3:CF:BA:
CD:31:F6:9C:75:71:91:B1:7F:67:45:25:E6:DD:C1:26:
D5:A4:E6:04:49:B0:F8:2C:6D:21:41:26:83:25:04:AB:
52:72:90:E9:3E:73:CA:FF:50:90:FE:D2:82:67:47:F9:
F2:33:9C:91:7F:06:84:D1:34:4D:91:88:C7:DC:5A:2F
Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
Subject Key Identifier:
36:DC:26:B6:F1:33:50:DE:DF:68:C8:4E:96:84:22:5D:59:64:A3:0C
Basic Constraints:
CA : false
Path Length Constraint: UNLIMITED
OCSP Server:
http://ocsp.sectigo.com
Issuing Certificate URL:
http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
Key Usage:
Digital Signature
Key Encipherment
Extended Key Usage:
Server Auth
Client Auth
DNS Names:
mail.neopharmlabs.com
www.mail.neopharmlabs.com
Certificate Signature Algorithm: SHA256-RSA
Certificate Signature:
D5:FC:82:E8:A8:D2:EA:E0:6B:47:61:BC:2D:9D:6B:81:
21:B9:59:49:5B:D2:8B:71:7E:56:F5:47:88:5C:C4:74:
38:E4:0C:25:9D:A9:04:9B:B4:9D:15:34:CD:D4:13:74:
FA:59:D5:74:6D:2A:4D:B4:E4:03:39:95:4C:7B:81:07:
28:CD:FE:6B:16:5C:11:28:75:9F:96:45:EC:8F:19:25:
26:65:58:CE:EE:3E:2A:38:0F:A2:31:0D:91:C6:F4:99:
1C:39:D8:1A:00:78:CE:0B:24:14:E8:33:A3:2C:66:65:
5C:EA:0A:B6:29:3D:D6:C3:18:12:A2:78:20:46:C6:A6:
07:A3:94:09:78:73:29:43:FD:8C:7C:C3:DC:57:71:13:
B5:73:AF:2B:13:2C:58:F8:A6:76:A7:3C:A5:66:8D:8B:
11:CE:D3:7C:42:F6:9A:2C:4E:F4:57:BF:8B:44:64:F7:
89:E8:E3:45:94:96:8D:C8:D7:ED:2A:89:E8:BA:3B:EF:
FD:D7:59:19:B4:1F:1C:16:25:9D:84:87:FD:46:CD:91:
AF:F7:42:32:03:16:4D:03:74:28:1B:5E:59:E2:64:F6:
AA:B4:40:2A:D0:6C:CB:FD:89:DB:35:E2:51:34:5C:B0:
CE:F6:54:42:E2:EF:26:D7:0A:7D:5E:ED:4B:E3:11:29
404 Not Found
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
2024-05-20
Header
Banner
Products
CName
HTTP/1.1 404 Not Found
Connection: close
Content-Length: 536
Content-Type: text/html
Date: Mon, 20 May 2024 12:51:32 GMT
mail.neopharmlabs.com:500
199.255.29.164 199.255.29.164 199.255.29.164
加拿大
/
Quebec
/
Blainville
ASN: 40108
Organization: LOGNET
neopharmlabs.com neopharmlabs.com
2024-01-01
共 9 条
- 10条/页
无数据
- 1